JPS60169495A - Modified dna and use thereof - Google Patents

Modified dna and use thereof

Info

Publication number
JPS60169495A
JPS60169495A JP2777584A JP2777584A JPS60169495A JP S60169495 A JPS60169495 A JP S60169495A JP 2777584 A JP2777584 A JP 2777584A JP 2777584 A JP2777584 A JP 2777584A JP S60169495 A JPS60169495 A JP S60169495A
Authority
JP
Japan
Prior art keywords
dna
sample
polynucleotide
polydeoxynucleotide
terminal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2777584A
Other languages
Japanese (ja)
Inventor
Tsunehiko Fukuda
福田 常彦
Ryuji Marumoto
丸本 龍二
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Priority to JP2777584A priority Critical patent/JPS60169495A/en
Publication of JPS60169495A publication Critical patent/JPS60169495A/en
Pending legal-status Critical Current

Links

Landscapes

  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

NEW MATERIAL:A polydeoxynucleotide having hapten linked directly or through a ligand to the phosphoric acid moiety at the 5'-terminal. USE:A detection reagent for viral genes or abnormal chromosomes by the method for nonradioactive nucleic acid hybridization. PREPARATION:A modified DNA obtained by reacting a hepten formation reagent, e.g. 2,4-dinitrophenylethylenediamine, with the phosphoric acid moiety at the 5'-terminal of a poly DNA, e.g. hepatitis B viral DNA. The resultant modified DNA is then hybridized with a polynucleotide in a sample immobilized in a cell or support, and an antidinitrophenyl antibody labeled with fluorescence or an enzyme to introduce a label into the sample. The optical response caused by optical excitation or addition of a substrate is sensed to detect specific base sequence in the sample.

Description

【発明の詳細な説明】 本発明は変性された新規DNAおよびその用途に関する
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a novel modified DNA and its uses.

生化学研究において放射性同位元素を用いる実験は敏感
な方法として広く利用されている。しかし被曝の危険性
や廃棄物処理などに慎重な配慮が要求され、これらの実
験を行う上には莫大な費用と特殊な空間を要する。さら
に32Pおよび125工などの半減期は短かく、これら
を含有する試薬は保存がきかないため用事調製といった
不便さがつきまとう。
Experiments using radioactive isotopes are widely used as sensitive methods in biochemical research. However, careful consideration must be given to the risk of radiation exposure and waste disposal, and conducting these experiments requires enormous amounts of money and special space. Furthermore, the half-lives of 32P and 125F are short, and reagents containing them cannot be stored, resulting in the inconvenience of having to prepare them on-the-go.

一方、現在分子生物学において特定の遺伝子の検出ある
いは同定のだめに、それらと相補的な塩基配列を持つデ
オキシヌクレオチド(以下DNAと略記することがある
)あるいはRNAフラグメントによる核酸ハイブリッド
形成法が繁用されている。現在この方法は主として32
Pを使用しているが、その短い寿命故に基礎研究のみに
限定され、病院などにおける臨床検査の一手段としては
利用されていない。
On the other hand, currently in molecular biology, nucleic acid hybridization methods using deoxynucleotides (hereinafter sometimes abbreviated as DNA) or RNA fragments that have complementary base sequences are often used to detect or identify specific genes. ing. Currently, this method mainly uses 32
However, due to its short lifespan, it is limited to basic research and is not used as a means of clinical testing in hospitals.

ウイμス遺伝子あるいは診断に価する異常染色体など特
定DNA配列を簡便かつ迅速に検出することは臨床にお
いて特に重要であシ、ある種のウィルス性疾患のように
抗原が検出されない場合でも、生体組織中のウィルスゲ
ノムを直接検出することが望まれている。
It is especially important in clinical practice to easily and quickly detect specific DNA sequences such as virus genes or abnormal chromosomes that are worth diagnosing. It is desired to directly detect the virus genome inside.

最近、非放射性免役診断法は充分放射性免疫診断法に匹
敵することが示されているが、本発明者らは螢光免疫ア
ッセイや酵素免疫アッセイの手法を核酸ハイブリッド形
成法と結合させることによル高16度の特定遺伝子診断
法を開発できると考え、鋭意研究を行い本発明を完成し
た。
Recently, non-radioactive immunodiagnostic methods have been shown to be fully comparable to radioactive immunodiagnostic methods, but the present inventors have combined fluorescence immunoassay and enzyme immunoassay techniques with nucleic acid hybridization methods. Believing that it would be possible to develop a specific genetic diagnostic method with a 16-degree level, we conducted extensive research and completed the present invention.

すなわち本発明は、5′末端のリン酸部に直接波たはリ
ガンドを経てハプテンを結合せしめてなるポリデオキシ
ヌクレオチド、ならびに該ポリデオキシヌクレオチドを
細胞中あるいは支持体に固定された試料中のポリヌクレ
オチドとハイブリダイズさせ該バイブリドに免疫学的手
法で螢光または酵素標識を導入し、光励起または基質添
加によって生じる光応答を検知することを特徴とするポ
リヌクレオチド中の特定塩基配列の検出法を提供するも
のである。
That is, the present invention provides a polydeoxynucleotide in which a hapten is bound to the 5'-terminal phosphate moiety directly or via a ligand, and a polydeoxynucleotide in which the polydeoxynucleotide is immobilized in cells or on a support. Provided is a method for detecting a specific base sequence in a polynucleotide, which comprises hybridizing with a polynucleotide, introducing a fluorescent or enzyme label into the hybrid using an immunological method, and detecting a photoresponse caused by photoexcitation or addition of a substrate. It is something.

上記変性されたポリデオキシヌクレオチドに関し、ハプ
テンは低分子であっても抗原性を有するものであればい
ずれでもよいが、ハプテンに対する抗体の入手容易性か
ら2.4−ジニトロフェニルなどのジニトロベンゼン誘
導体、ビオチノイル、イミノビオチノイルなどビオチン
誘導体、アルドステロン。17−β−エストラジオ−μ
、テストヌテロンなどステロイド類、ジフェニルヒダン
トインなどヒダントイン誘導体が挙げられ、とシわけ2
,4−ジニトロフェニルが好ましい。
Regarding the above-mentioned modified polydeoxynucleotide, the hapten may be any low molecular weight hapten as long as it has antigenicity, but due to the ease of obtaining antibodies against the hapten, dinitrobenzene derivatives such as 2,4-dinitrophenyl, Biotin derivatives such as biotinoyl and iminobiotinoyl, and aldosterone. 17-β-estradio-μ
, steroids such as testonuterone, and hydantoin derivatives such as diphenylhydantoin.
,4-dinitrophenyl is preferred.

ハプテンは直接ポリデオキシヌクレオチドの5′末端の
リン酸部に結合していてもよいが、リガンドを経てポリ
デオキシヌクレオチドのび末端のリン酸部に結合してい
ることが好ましい。該リガンドとしては、式−A−Z−
(式中、Aは結合手または式−X−(CH2)n−(X
はO、NHまたは結合手を、nは1〜8の整数を示す)
を、2はOまたはNHを示し、ハプテンはAに、ヌクレ
オチドの5′末端リン酸部は2に結合している〕で表わ
される基が挙げられる。なかでもリガンドとして式、N
il (CH2)nNH(nは上記と同意義)であるも
のが好ましく、とシわけnが2であるものが好ましい。
Although the hapten may be directly bound to the 5'-terminal phosphate moiety of the polydeoxynucleotide, it is preferably bound to the 5'-terminal phosphate moiety of the polydeoxynucleotide via a ligand. The ligand has the formula -A-Z-
(wherein A is a bond or a formula -X-(CH2)n-(X
represents O, NH or a bond, n represents an integer from 1 to 8)
, 2 represents O or NH, the hapten is bonded to A, and the 5'-terminal phosphate portion of the nucleotide is bonded to 2]. Among them, as a ligand, the formula, N
It is preferable that il (CH2)nNH (n has the same meaning as above), and preferably that n is 2.

上記ポリデオキシヌクレオチド(以下、ポリDNAと略
称することがある)は、検出対象となる遺伝子、ウィル
スなどのポリヌクレオチドの特定塩基配列に相補的なポ
!JDNAである。該ポリDNAは塩基数として8以上
、好ましくは12〜1.000である。
The above-mentioned polydeoxynucleotide (hereinafter sometimes abbreviated as polyDNA) is a polynucleotide that is complementary to a specific base sequence of a polynucleotide such as a gene or virus to be detected. It is JDNA. The polyDNA has 8 or more bases, preferably 12 to 1,000 bases.

上記ポリDNAに関し、ボ!JDNAの鎖長の短いもの
は公知の化学合成によって大量に得ることも容易である
。鎖長の短いものは、ハイグリッド体形成能の点で劣る
ためCOG含量の高いものが望ましい。一般にゲノムの
特定な箇所を特異的に検出する場合には比較的鎖長の短
いものがふされしく、鎖長の長いプローブはゲノムの広
領域にわたって同定・検出する場合には有用であるが、
若干特異性を欠く傾向にある。
Regarding the polyDNA mentioned above, Bo! JDNA with a short chain length can be easily obtained in large quantities by known chemical synthesis. Those with a short chain length are inferior in terms of the ability to form a high grid body, so those with a high COG content are desirable. In general, probes with a relatively short chain length are appropriate when specifically detecting a specific part of the genome, while probes with a long chain length are useful when identifying and detecting a wide region of the genome.
It tends to lack specificity.

比較的長い鎖長のグローブは、クローニングされたDN
Aを二本鎖のまま制限酵素によって切り出されるが、こ
こで得られる異った鎖長フヲグメントはゲ/I/罹気泳
動などで分離して使用されてもよいが、混合物のままハ
プテン化しても有利に使用できる。
The relatively long chain length indicates the cloned DN.
A is cut out as a double strand by a restriction enzyme, and the fragments with different chain lengths obtained here may be separated and used by gel/I/selectivity electrophoresis, but they can be haptenized as a mixture. can also be used to advantage.

本発明の変性されたDNAを、例えばB型肝炎ウィルス
の存在を検出するために用いる場合、ポ!JDNAとし
て例えば、表面抗原蛋白遺伝子とコア蛋白遺伝子との間
に存在する塩基配列に相補的なTCTTATGTAAG
ACCT であるか、B型肝炎ウィルスDNAを制限酵
素5au3Aで分解して得られる平均200塩基対のポ
リDNAであることが好ましい。
When the denatured DNA of the present invention is used to detect the presence of hepatitis B virus, for example, po! As JDNA, for example, TCTTATGTAAG complementary to the base sequence existing between the surface antigen protein gene and the core protein gene.
ACCT or polyDNA with an average size of 200 base pairs obtained by digesting hepatitis B virus DNA with restriction enzyme 5au3A.

本発明の変性されたDNAは、完全なボ9DMAに、所
望によシリガントを有するハプテン化試薬を反応させる
かまたはハプテンを有するポリDNAの一部を残シのポ
!JDNAまたはDNAと縮合させることにより製造で
きる。
The denatured DNA of the present invention can be obtained by reacting complete Bo9DMA with a haptenizing reagent containing a siligant, as desired, or by leaving a part of the polyDNA containing a hapten. It can be produced by condensing with JDNA or DNA.

具体的には、例えば2,4−ジニトロフェニルエチレン
ジアミンやビオチンなどハプテン化試薬とポリDNAと
を縮合して製造することができる。
Specifically, it can be produced by condensing a haptenizing reagent such as 2,4-dinitrophenylethylenediamine or biotin with polyDNA.

ハゲテン化試薬の有するアミノ基をポリDNAのリン酸
残基と反応させる場合は、トリフェニルホスフィンと2
,2′−ジピリlジμジス〃フイドなど脱水触媒の存在
下反応させることができ、通常N、N−ジメチルホルム
アミド、ジメチルスルオキシド、水やこれらの混合物な
ど極性溶媒中行う。反応温度は一10〜10℃である。
When reacting the amino group of the halogenation reagent with the phosphoric acid residue of polyDNA, triphenylphosphine and 2
The reaction can be carried out in the presence of a dehydration catalyst such as , 2'-dipyryldiμ disulfide, and is usually carried out in a polar solvent such as N,N-dimethylformamide, dimethyl sulfoxide, water, or a mixture thereof. The reaction temperature is -10 to 10°C.

ハブテン化試薬の有する力〃ホキシル基を反応させる場
合は、酸ハロゲン化物として用いることが好ましい。
Power of Habtenizing Reagent: When reacting a phoxyl group, it is preferable to use it as an acid halide.

かくして得られる本発明の変性されたDNAは、抽出、
カラムクロマトグラフィー、再結晶、再沈設など通常の
化学的操作によυ分離、精製することができる。
The denatured DNA of the present invention thus obtained is extracted,
It can be separated and purified by standard chemical operations such as column chromatography, recrystallization, and reprecipitation.

本発明の変性されたDNAは低毒性であシ、安全に、例
えば以下の用途に用いることができる。
The modified DNA of the present invention has low toxicity and can be safely used, for example, in the following applications.

本発明の変性されたDNAを用いるポリヌクレオチド中
の特定塩基配列の検出は、例えば以下の方法によって行
うことができる。
Detection of a specific base sequence in a polynucleotide using the denatured DNA of the present invention can be carried out, for example, by the following method.

検出しようとするポリヌクレオチドを常法によシニトロ
セ〜ロースフィルター等の支持体に固定し、所望によジ
アルカリ、加熱等によシ変性させ、一本鎮ポリヌクレオ
チドとする。
The polynucleotide to be detected is immobilized on a support such as a sinitrose filter or the like by a conventional method, and if desired, denatured with dialkali, heat, etc. to obtain a single polynucleotide.

上記ヌクレオチドを固定したフィルターとハプテン化さ
れたDNA(I)MAプローブ)を緩衝液中でハイブリ
ダイズさせる。
The nucleotide-immobilized filter and the haptenized DNA (I) MA probe) are hybridized in a buffer solution.

上記処理したフィルターを、トリス−塩酸、ヒトアμプ
ミン等を含有する食塩水で洗浄し、ウサギ抗ジニトロフ
ェニルー斗血清アルブミン(ウサギ抗DNP−BSA)
など抗ハプテンエgG あるいは抗血清と反応させる。
The above-treated filter was washed with a saline solution containing Tris-HCl, human apmin, etc., and rabbit anti-dinitrophenyl-dou serum albumin (rabbit anti-DNP-BSA) was added.
React with anti-hapteneggG or antiserum.

抗ハプテンIgG 等は、ヒトアμプミンやヤギ血清を
含む希釈食塩水として用いることが好ましい。
Anti-hapten IgG and the like are preferably used in the form of a diluted saline solution containing human apmin or goat serum.

食塩水等で洗浄後、該反応させたフィルターを西洋ワサ
ビ・べpオキシダーゼ標識したヤギ抗つfキIgG 抗
体など各種ペルオキシダーゼやルシフェラーゼで酵素標
識した抗IgG 抗体やエテノヌクレオチド、アミノヘ
キサンアデノシンヌクレオチドなどで螢光標識した抗1
gG 抗体と反応さ上記反応したフィルターを光励起ま
たは基質添加して、生ずる光応答を検知することによシ
ボジヌクレオチド中の特定塩基配列の有無を知ることが
できる。基質としては過酸化水素など、発色剤としては
オルトジアニンジンなどを例示することができる。
After washing with saline, the reacted filter is treated with various peroxidases such as horseradish-vep oxidase-labeled goat anti-Tf IgG antibodies, luciferase-enzyme-labeled anti-IgG antibodies, ethenonucleotides, aminohexane adenosine nucleotides, etc. Fluorescently labeled anti-1
The presence or absence of a specific base sequence in the sibodinucleotide can be determined by photoexciting or adding a substrate to the reacted filter with the gG antibody and detecting the resulting photoresponse. Examples of the substrate include hydrogen peroxide, and examples of the coloring agent include ginseng orthodia.

本発明の変性されたDNAを用いるポリヌクレオチド中
の特定塩基配列の検出法によシ、B型肝炎ウィルス(H
BV)、成人白血病ウィルス(ATLAV)、大白血球
抗原(HI、 A )等の遺伝子を検出することができ
、B型肝炎や成人白血病等の診断やHL A型判定のた
めに有用である。
By the method of detecting a specific base sequence in a polynucleotide using denatured DNA of the present invention, hepatitis B virus (H
It can detect genes such as BV), adult leukemia virus (ATLAV), and large leukocyte antigen (HI, A), and is useful for diagnosing hepatitis B, adult leukemia, etc., and determining HLA type.

具体的には、診断の対象となる動物(マウス。Specifically, the animal targeted for diagnosis (mice).

イヌ、ヒトなど)の血清等を用い本願明細喬実施例6記
戦の方法や公知(例えば、プロシーディング ナショナ
ル アカデミ−オプ サイエンスUSA 第79巻、7
522−7526頁。
Using serum from dogs, humans, etc., the method described in Example 6 of the present specification and known methods (for example, Proceedings of the National Academy of Sciences USA Vol. 79, 7) are used.
pp. 522-7526.

1982年)の方法に準じて行うことができる。(1982).

本練明細書中記号の意義は以下のとおりである。The meanings of the symbols in this specification are as follows.

A:デオキシアデニル酸残基 C:デオキシシ手ジルR
NST:チミジ〃酸残基 Ph:フエ二μ G:デオキシグアニμ酸残基 Bz:ベンゾイル以下実
施例によって本発明を具体的に説明するが、本発明はこ
れらに制限されるものではない。
A: Deoxyadenylic acid residue C: Deoxyadenylic acid residue R
NST: Thymidic acid residue Ph: Feniμ acid residue Bz: Deoxyguaniμ acid residue Bz: Benzoyl The present invention will be specifically explained below with reference to Examples, but the present invention is not limited thereto.

実施例中、保護されたヌクレオチドの保蒋基は、5′位
についてはジメトキシトリチμであシ、リン酸について
はp−クロロフェニルトβ−シアノエ5′位を脱保護し
た保護T460qと1−メチルイミダゾ−/l’120
μlをピリジン10−/に溶解し、ジフェニルアミノ燐
酸クロリド400りを加えた。
In the examples, the protecting group of the protected nucleotide was dimethoxytrithiμ for the 5' position, and p-chlorophenyltoβ-cyanoe for the phosphoric acid, protected T460q and 1-methylimidazo which deprotected the 5' position. -/l'120
The solution was dissolved in 10 μl of pyridine and 400 μl of diphenylaminophosphoric acid chloride was added.

6時間後と20時間後に上記燐酸化剤40oqと1−メ
チルイミダゾ−/l’120μ!を追加し、4時間後に
IM酢酸カリウム5mlを加えて1o分間攪拌。反応液
にクロロホルム20*tを加えて抽出し、クロロホルム
層を0.5M燐酸二水素カリウム、次いで水で洗い、濃
縮乾固。残留物をシリカゲ/L/30gを用い、0H0
13MeOH(97: 3 )で精製し、目的物370
qを得た。R’f= 0.11(キーゼルゲ/’ 60
F’−254,メルり社、クロロホルム−メタノ−/L
/ 19:14/V)実施例2 ダとを乾燥ピリジンIyxl中メシチレンスμホニμニ
トロトリアシー#(MSNT)70qの存在下1時間線
合。反応液に少量の水を加え、濃縮乾固。
After 6 hours and 20 hours, 40oq of the above phosphorylating agent and 120μ of 1-methylimidazo-/l'! After 4 hours, 5 ml of IM potassium acetate was added and stirred for 1 minute. Chloroform 20*t was added to the reaction solution for extraction, and the chloroform layer was washed with 0.5M potassium dihydrogen phosphate and then with water, and concentrated to dryness. The residue was 0H0 using silikage/L/30g.
Purified with 13MeOH (97:3) to obtain the target product 370
I got q. R'f = 0.11 (Kieserge/' 60
F'-254, Merlisha, chloroform-methanol/L
/ 19:14/V) Example 2 Coagulation of 1 hour in the presence of 70q of mesitylene μhoniμnitrotriacey # (MSNT) in dry pyridine Iyxl. Add a small amount of water to the reaction solution and concentrate to dryness.

残渣をア十トンに溶解し、白湯するまで水を加えたのち
りクログレップRP−8(メルり社)309の’Jフラ
ム吸着させ、アセトン−酢酸トリエチzし7ミン(0,
01M)3:2V/V 混液Zoom/で洗い、次いで
上記7 : 3 V/V混液1ooゴで溶出される分画
を濃縮乾固。残留物を少量のクロロホルムに溶解し、こ
れをシクロヘキサン中に滴下して得られる沈殿を遠心分
離し、白色粉末84ダを得た。
The residue was dissolved in Atenton, water was added until it was boiling, and the residue was adsorbed with 'J flam of Chiricrogrep RP-8 (Merurisha) 309, and acetone-triethyl acetate was added with 7mine (0,
01M) Wash with 3:2 V/V mixture Zoom/, and then concentrate the fraction eluted with the above 7:3 V/V mixture 100 to dryness. The residue was dissolved in a small amount of chloroform and dropped into cyclohexane, and the resulting precipitate was centrifuged to obtain 84 d of white powder.

(1)(phNHJo−TC:TTATGTの合成:8
NT100qで縮合させ、(1)の方法と同様にして粉
末状の目的物60IIvを得た。
(1) (Synthesis of phNHJo-TC:TTATGT: 8
Condensation was carried out with NT100q, and powdered target product 60IIv was obtained in the same manner as in method (1).

(In) (phN■)2 ’1−o−TCTTATG
TAAGACCTOBzの合成(1,小計11へ057
テ′pマラ:GACCTOBz 401M;lとをMS
NTlooりを用いて縮合し、常法に従って目的物60
#7を単離した。
(In) (phN■)2 '1-o-TCTTATG
Synthesis of TAAGACCTOBz (1, 057 to subtotal 11
Te'p Mara: GACCTOBz 401M;l and MS
Condensate using NTloo, and obtain the target product 60 according to a conventional method.
#7 was isolated.

(1v)完全保護ペンタデカマーの保護基除去:完全保
護ペンタデカマー60qを#酸−トリエチμアミン混液
(2:IV/V) 1.5解lに溶解。
(1v) Removal of protecting group from fully protected pentadecamer: Dissolve 60q of fully protected pentadecamer in 1.5 ml of #acid-triethymuamine mixture (2:IV/V).

亜硝酸イソアミ7し0.15 mlを加え35℃で7時
間攪拌。反応液を濃縮乾固したのち、ピリジンを加えて
再度濃縮し、亜硝酸イソアミルを完全に除去。
Add 0.15 ml of Isoamide Nitrite 7 and stir at 35°C for 7 hours. After concentrating the reaction solution to dryness, pyridine was added and concentrated again to completely remove isoamyl nitrite.

残渣に濃アンモニア水5slを加え25℃で20時間密
栓放置したのち、60℃で4時間加熱。アンモニア水を
留去し、残渣を0.01M重炭酸トリエチルアミンに溶
かし、エーテルで2回洗浄。次にセファデックスG−5
0で最初に溶出される分画を分取し、続いてイオン交換
高速液体クロマドグ7フイー(−/<−f−VIL/’
3 AX −10、φ0,4×30 cva 、 Na
H2PO4緩衝液(pH6,3)による直線勾配溶出法
、0.15M(15%エタノ−μ含有)から0.3 M
 (30%エタノール含有)まで1o分間で変化〕にお
いて最も遅く溶出される主分画を分取し、5EP−PA
K(ウォーターズ)で脱塩し、逆相高速液体クロマトグ
ラフィー(ヌクレオシル−〇1B)で単一のピークを示
すもの350.D。
5 sl of concentrated ammonia water was added to the residue, and the mixture was left sealed at 25°C for 20 hours, and then heated at 60°C for 4 hours. Aqueous ammonia was distilled off, and the residue was dissolved in 0.01M triethylamine bicarbonate and washed twice with ether. Next, Sephadex G-5
The fraction eluted first at
3 AX -10, φ0, 4×30 cva, Na
Linear gradient elution with H2PO4 buffer (pH 6,3), from 0.15 M (containing 15% ethanol-μ) to 0.3 M
(containing 30% ethanol) in 10 minutes], the main fraction eluting most slowly was collected, and 5EP-PA
350. Desalted with K (Waters) and showing a single peak in reverse phase high performance liquid chromatography (Nucleosyl-01B). D.

を得た。氷晶は細菌のアルカリホスファターゼで5′位
を脱燐酸したのち、32Pで1位を標識したATPとポ
リヌクレオチドキナーゼで5′位を放射標識し、マキサ
ム−ギルバート法によって目的とする基糸配列に一致す
ることを確認した。
I got it. The ice crystals are dephosphorylated at the 5' position with bacterial alkaline phosphatase, and then radiolabeled at the 5' position with ATP labeled with 32P at the 1st position and polynucleotide kinase, and then converted into the desired base thread sequence using the Maxam-Gilbert method. Confirmed that they match.

実施例3 実施例20v)で得たペンタデカマー850μgを水3
0μ!に溶解。ここに2,4−ジニトロフェニルエチレ
ンジアミン13qのN、N−ジメチルホpムアミド溶液
300μmを加え、更に0℃でトリフェニルホスフィン
391EIと2.’j−ジピリジルジスμフィト33ダ
を加えた。その後同温度で1時間毎にトリフェニルホス
フィンと2 、2’−ジピリジμジスpフィトを一回目
と同量;・さらに2度にわたって加え、反応液に水2g
/を加え、酢酸エチ/L/2 mlで2度洗浄した。水
層を濃縮乾固し、残渣を少量の0.OIM重度酸トリエ
チμアミンに溶かし、セファデックスG−50,次いで
高速液体クロマトグラフィー(パーチシ/l/5AX−
10)によって精製し、200μgの黄色粉末として、
2.4−ジニトロフエニμmNHCH2CH2NH−P
O2−TCTTATGTAAGACCT (D N A
プローブ)を得た。
Example 3 850 μg of pentadecamer obtained in Example 20v) was added to 3 parts of water.
0μ! Dissolved in. A 300 μm solution of 2,4-dinitrophenylethylenediamine 13q in N,N-dimethylfopamide was added thereto, and triphenylphosphine 391EI and 2. 'J-dipyridyldisμphyto 33 da was added. Thereafter, at the same temperature, triphenylphosphine and 2,2'-dipyridiμdisp-phyto were added in the same amount as the first time every hour; and two more times, and 2 g of water was added to the reaction solution.
/ was added, and the mixture was washed twice with ethyl acetate/L/2 ml. The aqueous layer was concentrated to dryness, and a small amount of the residue was collected. OIM heavy acid was dissolved in triethyl amine, Sephadex G-50, and then high performance liquid chromatography (particyl/l/5AX-
10) as a 200 μg yellow powder,
2.4-dinitrophenymuNHCH2CH2NH-P
O2-TCTTATGTAAGACCT (DNA
probe) was obtained.

夾方市例4 B型肝炎つィルスAdw の全遺伝子を含むpBR32
2由来のプラスミドpBR322−EcoR工/I(B
Y933 (特開昭58−194897号公報参照)1
μ9をEcoRIで切断し、アガロース電気泳動に付し
、臭化エチジウムで螢光染色すると二本のバンドが検出
された。分子量の大きいバンド(ウイメルゲノムを含む
)をニトロセルロースニ転位させ、七μロース上に固定
されたD)JAを80℃で3時間加熱変成させ、フィμ
ターを実施例3で得られたDNAプローブ2μすと緩衝
液200μI中でハイブリダイズさせた。七ルロースを
3%のヒト・アルブミンを含む食塩水(9%NaC1の
10mM)リス・塩酸緩衝液、pH7,4)に浸し、食
塩水で洗い、ウサギ抗DNP−BSA血清(10倍稀釈
)の3%ヒト・1μプミン、10%ヤギ血清を含む食塩
水稀釈液に2時間浸した。食塩水で5回洗い、西洋ワサ
ビ・ペルオキシダーゼ標識したヤギ抗つサギIgCtc
体(200倍稀釈)の3%ヒト・アルブミン、10%ヤ
ギ血清を含む食塩水1に2時間浸した。再び食塩水で5
回洗い、0.0025%オルトジアニシジン、0.01
%過酸化水素(10mM )リスー゛塩酸緩衝液、 p
H14)に30分間浸し、水洗、乾燥すると、ウィルス
ゲノムを含むバンドのみ赤褐色を呈し、pBR322由
来のバンドは全く着色しなかった。
Kakata City Example 4 pBR32 containing all genes of hepatitis B virus Adw
Plasmid pBR322-EcoR engineering/I (B
Y933 (Refer to Japanese Unexamined Patent Application Publication No. 1988-194897) 1
When μ9 was cut with EcoRI, subjected to agarose electrophoresis, and fluorescently stained with ethidium bromide, two bands were detected. D) JA immobilized on 7μ loin was denatured by heating at 80°C for 3 hours, and the high molecular weight band (including the Wimel genome) was translocated onto nitrocellulose.
The sample was hybridized with 2 μl of the DNA probe obtained in Example 3 in 200 μl of buffer. Heptululose was soaked in saline (10 mM Lis-HCl buffer with 9% NaC1, pH 7.4) containing 3% human albumin, washed with saline, and treated with rabbit anti-DNP-BSA serum (10 times diluted). It was soaked for 2 hours in a diluted saline solution containing 3% human 1μ pummin and 10% goat serum. Goat anti-heron IgCtc washed 5 times with saline and labeled with horseradish peroxidase.
The body (diluted 200 times) was immersed in saline solution 1 containing 3% human albumin and 10% goat serum for 2 hours. 5 with salt water again
Wash twice, 0.0025% orthodianisidine, 0.01
% hydrogen peroxide (10mM) in hydrochloric acid buffer, p
When immersed in H14) for 30 minutes, washed with water, and dried, only the band containing the virus genome became reddish brown, and the band derived from pBR322 was not colored at all.

実施例5 プラスミドpBR322にB型肝炎ウィルスDNAを組
み込みクローニングして得られるプラスミドpBR32
2−EcoRI/HBV933 (前出)2.3#を制
限酵素EcoR工で消化し、アガローヌゲ/L/電気泳
動で分離精製し、肝炎ウィルスD N A (470μ
g )を得た。この内390μfを制限酵素5au3A
で分解後、精製して平均200塩基対のDNAフラグメ
ントを含む混合物(220μg )を得た。このDNA
のうち50μすを2.4−ジニトロフェニルエチレンジ
アミン(13,5q)l:KN、N−ジメチルホpムア
ミド(300pJ )−水(30μ! )の混合液に溶
かし、水冷下にトリフェニルホスフィン(31g)と2
,2′−ジピリミジμジスルフィド(33ffN)を加
えた。後2者の試薬を1時間毎にさらに2回加え、最後
に加えてから1時間後に水(またt)と酢酸エチ/’(
4Fl+/)を加えて抽出した。水層を7農縮し、この
溶液をセファデツクヌG−250カラム(0,6X 2
5c+n)の上端に注いだ。カフムを0.15モルの食
塩を含むトリス−塩酸緩衝液(20ミリモ/I/濃度、
pH8,0)で展開し、最も早く溶出するピークを集め
た。エタノ−/L’S殿により、2.4−ジニトロフエ
ニμで修飾されたDNA混合物(40gg )を得り。
Example 5 Plasmid pBR32 obtained by integrating hepatitis B virus DNA into plasmid pBR322 and cloning
2-EcoRI/HBV933 (previously) 2.3# was digested with the restriction enzyme EcoR, separated and purified by agaronuge/L/electrophoresis, and hepatitis virus DNA (470μ
g) was obtained. Of this, 390 μf was converted into restriction enzyme 5au3A.
After decomposition, the mixture was purified to obtain a mixture (220 μg) containing DNA fragments with an average size of 200 base pairs. this DNA
Dissolve 50μ of this in a mixture of 2,4-dinitrophenylethylenediamine (13,5q) l:KN,N-dimethylhopamide (300pJ) and water (30μ!), and add triphenylphosphine (31g) under water cooling. and 2
, 2'-dipyrimidiμ disulfide (33ffN) was added. The latter two reagents were added twice more every hour, and 1 hour after the last addition, water (also t) and ethyl acetate/'(
4Fl+/) was added for extraction. The aqueous layer was reduced 7 times, and this solution was transferred to a Sephadecnu G-250 column (0.6X 2
5c+n). Kahum was dissolved in Tris-HCl buffer containing 0.15 molar salt (20 mmol/I/concentration,
pH 8,0), and the earliest eluting peak was collected. A DNA mixture (40 gg) modified with 2,4-dinitrophenyl was obtained by ethanol/L'S.

ニトロセμロースフイμターにプラスミドPBR322
−EcoRI/HIIV933の種々の濃度の希釈水溶
液をスポットし、8(1,3時間加熱乾蝶し、次いでこ
の74!ターを常法どう)ハイブリダイゼーションの前
処理に付した。前述のジニトロフェニルエチレンジアミ
ンでハプテン化LcDNA(1μg )をプローブとし
、400μEの溶液中、+oM 16時間、フィルター
上に固定したDNAとハイブリダイゼーションさせた。
Plasmid PBR322 in Nitrose μLose Phytter
Diluted aqueous solutions of -EcoRI/HIIV933 at various concentrations were spotted, heated and dried for 1 to 3 hours, and then subjected to pretreatment for hybridization using a conventional method. The aforementioned dinitrophenylethylenediamine-haptenated LcDNA (1 μg) was used as a probe and hybridized with the DNA immobilized on the filter in a 400 μE solution at +oM for 16 hours.

以後、実施例4と同様の酵素免疫法の諸過程を施した。Thereafter, the same enzyme immunoassay steps as in Example 4 were performed.

その結果フィルター上の1ナノグラムのpBR322−
EcoRI/HBV933 のスポットにまで明らかな
発色が認められた。
As a result, 1 nanogram of pBR322-
Clear color development was observed even in the EcoRI/HBV933 spot.

実施例6 B型肝炎表面抗原キャリヤーの血清(300μl)金2
%のドデV/X/硫酸ナトリウム、サケ精液DNA(4
0μ’i/It )およびプロテイナーゼx(2り/ 
ml )を含む150mM食in/ 10 mM ED
’rA/lQmM)リス塩酸(250/jJ)中に加え
、37℃で4時間インキュベートしたのち、等容の上記
緩衝液を飽和したフェノール、次いでクロロホルム/イ
ソアミルアμコール(24:1)で洗う。1/10容の
3M酢酸ナトリウムと2倍容のエタノ−μを用いてDN
Aを沈でんせしめ、乾燥する。これを0.3 M水酸化
ナトリウム(10μm )で室温下10分間変性させ、
2M酢酸アンモニウA(10gg )”t”1MTIL
、ニトロセルロース・フィルター上にスポットする。常
法通シのハイブリダイゼーションの前処理に付した後、
ハプテン化DNA(1μ9.400μJ )を用いて実
施例5と同様に処理するとスポットは特有の赤褐色を呈
する。
Example 6 Hepatitis B surface antigen carrier serum (300 μl) Gold 2
% Dode V/X/Sodium Sulfate, Salmon Semen DNA (4
0μ'i/It) and proteinase x (2i/It)
ml) containing 150mM meal in/10mM ED
'rA/lQmM) in lithic hydrochloric acid (250/jJ) and after incubation for 4 hours at 37°C, an equal volume of the above buffer is washed with saturated phenol and then with chloroform/isoamyl alcohol (24:1). DN using 1/10 volume of 3M sodium acetate and 2 volumes of ethanol-μ.
Precipitate A and dry. This was denatured with 0.3 M sodium hydroxide (10 μm) for 10 minutes at room temperature.
2M ammonium acetate A (10gg)"t"1MTIL
, spotted onto a nitrocellulose filter. After being subjected to conventional hybridization pretreatment,
When treated in the same manner as in Example 5 using haptenized DNA (1 μ9.400 μJ), the spots exhibit a characteristic reddish-brown color.

Claims (2)

【特許請求の範囲】[Claims] (1) ダ末端のリン酸部に直接またはりガントを経て
ハプテンを結合せしめてなるポリデオキシヌクレオチド
(1) A polydeoxynucleotide in which a hapten is bound directly to the phosphate moiety at the da terminal or via a Gantt.
(2) 5’末端のリン酸部に直接またはりガントを経
てハプテンを結合せしめてなるポリデオキシヌクレオチ
ドを、細胞中あるいは支持体に固定された試料中のポリ
ヌクレオチドとハイブリダイズさせ、該バイブリドに免
疫学的手法で螢光または酵素標識を導入し、光励起また
は基質添加によって生じる光応答を検知することを特徴
とするポリヌクレオチド中の特定塩基配列の検出法。
(2) A polydeoxynucleotide formed by binding a hapten directly to the 5'-terminal phosphate moiety or via a Gantt is hybridized with a polynucleotide in a cell or a sample immobilized on a support, and the hybrid is A method for detecting a specific base sequence in a polynucleotide, which comprises introducing a fluorescent or enzyme label using an immunological method and detecting a photoresponse caused by photoexcitation or addition of a substrate.
JP2777584A 1984-02-15 1984-02-15 Modified dna and use thereof Pending JPS60169495A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2777584A JPS60169495A (en) 1984-02-15 1984-02-15 Modified dna and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2777584A JPS60169495A (en) 1984-02-15 1984-02-15 Modified dna and use thereof

Publications (1)

Publication Number Publication Date
JPS60169495A true JPS60169495A (en) 1985-09-02

Family

ID=12230346

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2777584A Pending JPS60169495A (en) 1984-02-15 1984-02-15 Modified dna and use thereof

Country Status (1)

Country Link
JP (1) JPS60169495A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5317098A (en) * 1986-03-17 1994-05-31 Hiroaki Shizuya Non-radioisotope tagging of fragments
US7220854B1 (en) 1982-06-23 2007-05-22 Enzo Life Sciences, Inc. C/O Enzo Biochem, Inc. Sugar moiety labeled nucleotide, and an oligo- or polynucleotide, and other compositions comprising such sugar moiety labeled nucleotides
US8097405B1 (en) 1982-06-23 2012-01-17 Enzo Biochem, Inc. Nucleic acid sequencing processes using non-radioactive detectable modified or labeled nucleotides or nucleotide analogs, and other processes for nucleic acid detection and chromosomal characterization using such non-radioactive detectable modified or labeled nucleotides or nucleotide analogs

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7220854B1 (en) 1982-06-23 2007-05-22 Enzo Life Sciences, Inc. C/O Enzo Biochem, Inc. Sugar moiety labeled nucleotide, and an oligo- or polynucleotide, and other compositions comprising such sugar moiety labeled nucleotides
US8097405B1 (en) 1982-06-23 2012-01-17 Enzo Biochem, Inc. Nucleic acid sequencing processes using non-radioactive detectable modified or labeled nucleotides or nucleotide analogs, and other processes for nucleic acid detection and chromosomal characterization using such non-radioactive detectable modified or labeled nucleotides or nucleotide analogs
US5317098A (en) * 1986-03-17 1994-05-31 Hiroaki Shizuya Non-radioisotope tagging of fragments

Similar Documents

Publication Publication Date Title
CA1236410A (en) Nucleic acid hybridization assay
JP2801051B2 (en) Methods and reagents for detecting nucleobase sequences
JP2955759B2 (en) Methods for amplifying and detecting nucleic acid sequences
JP2683336B2 (en) Alternative nucleotide sequence identification means
EP0266399B1 (en) Replicative rna reporter systems
DK171822B1 (en) Modified nucleotides and methods for their preparation and detection
US5109124A (en) Nucleic acid probe linked to a label having a terminal cysteine
US4898951A (en) Compounds used as intermediates in the preparations of non-radioactive biological probes
US4822731A (en) Process for labeling single-stranded nucleic acids and hybridizaiton probes
Imberti et al. An immunoassay for specific amplified HCV sequences
JPS62240864A (en) Detection of material to be analyzed by energy transmission
JPS61195699A (en) Solution phase double crossing assay for detecting polynucleotide arrangement
JPH09500525A (en) Chemical method for amplifying and detecting nucleic acid sequences
JP3093116B2 (en) Nucleic acid detection method
JPS6160697A (en) Novel derived nucleic acid arrangement, manufacture and method of detecting nucleic acid or nucleic acid arrangement
EP0146039A2 (en) Hybridization assay with immobilization of hybrids by antihybrid binding
EP0146815B1 (en) Nucleic acid hybridization assay employing antibodies to intercalation complexes
US6270972B1 (en) Kit for detecting nucleic acid sequences using competitive hybridization probes
EP1107798A1 (en) A novel method of diagnosing, monitoring, staging, imaging and treating colon cancer
JPS60169495A (en) Modified dna and use thereof
JP3253181B2 (en) Photochemical labeling of nucleic acids using digoxigenin reagent
JPS611388A (en) Nucleotide hybrid forming probe
JPH01500353A (en) Nucleic acid detection probe containing 2'-deoxyadenosine derivative
JPH0531108B2 (en)
US4774176A (en) Sensitive tests for malignancies based on DNA detection